Benjamin Stanton, PhD

• Center for Childhood Cancer
  Principal Investigator
• Hematology/Oncology & BMT
  Principal Investigator
• Primary Department
  Center for Childhood Cancer

• St. Baldrick's Scholar Award, 2019
• NIH National Center for Advancing Translational Sciences Director’s Award, 2018

Ben Stanton, PhD, is a principal investigator in the Center for Childhood Cancer at the Abigail Wexner Research Institute at Nationwide Children’s Hospital, and assistant professor at The Ohio State University College of Medicine. Ben received his PhD from Harvard University, and Postdoctoral training at Stanford University School of Medicine and NIH. His group studies chromatin activation and epigenetic repression at the systems level, to gain insight into genome architecture in childhood cancers. He is motivated to understand the essential roles of chromatin regulatory complexes in low mutational burden tumors. For studies in the lab, interdisciplinary approaches are developed to ask (1) how aberrant chromatin repression can drive human disease, (2) why chromatin remodeling is under positive selection in certain pediatric tumors, and (3) whether new methods can enable insights into chromatin deregulation. Ben is excited about mentoring next-generation of scientist and for fundamental insights that enable translational advances.

Publications

Date of Appointment at Nationwide Children’s Hospital: 07/01/2019

Center for Childhood Cancer